Translation
Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.
Summary of Consolidated Financial Results
for the Year Ended December 31, 2022
(Based on Japanese GAAP)
February 10, 2023 | ||||||||||||||||||||||
Company name: | Nicca Chemical Co., Ltd. | |||||||||||||||||||||
Stock exchange listing: Tokyo, Nagoya | ||||||||||||||||||||||
Stock code: | 4463 | URL https://www.nicca.co.jp | ||||||||||||||||||||
Representative: | President and Representative | EMORI Yasumasa | ||||||||||||||||||||
Director, Member of the Board | ||||||||||||||||||||||
Inquiries: | General manager of Administration Division SAWASAKI Shoya | TEL 0776-24-0213 | ||||||||||||||||||||
Scheduled date of ordinary general meeting of shareholders: | March 28, 2023 | |||||||||||||||||||||
Scheduled date to file Securities Report: | March 29, 2023 | |||||||||||||||||||||
Scheduled date to commence dividend payments: | March 29, 2023 | |||||||||||||||||||||
Preparation of supplementary material on financial results: | Yes | |||||||||||||||||||||
Holding of financial results meeting: | Yes | (for the press) | ||||||||||||||||||||
(Amounts less than one million yen are rounded down) | ||||||||||||||||||||||
1. Consolidated financial results for the year ended December 31, 2022 (from January 1, 2022 to December 31, 2022) | ||||||||||||||||||||||
(1) Consolidated operating results | Percentages indicate year-on-year changes | |||||||||||||||||||||
Net sales | Operating profit | Ordinary profit | Profit attributable to | |||||||||||||||||||
owners of parent | ||||||||||||||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | |||||||||||||||
Year ended December 31, 2022 | 50,627 | - | 2,628 | - | 3,132 | - | 2,114 | - | ||||||||||||||
Year ended December 31, 2021 | 48,474 | 17.7 | 2,453 | 73.2 | 2,706 | 64.5 | 2,595 | 148.5 | ||||||||||||||
Earnings per share | Diluted earnings per | Profit attributable to | Ordinary profit/total | Operating profit/net | ||||||||||||||||||
share | owners of | assets | sales | |||||||||||||||||||
parent/equity | ||||||||||||||||||||||
Yen | Yen | % | % | % | ||||||||||||||||||
Year ended December 31, 2022 | 134.08 | - | 8.0 | 5.7 | 5.2 | |||||||||||||||||
Year ended December 31, 2021 | 164.82 | - | 11.3 | 5.0 | 5.1 | |||||||||||||||||
(2) Consolidated financial position | ||||||||||||||||||||||
Total assets | Net assets | Equity ratio | Net assets per share | |||||||||||||||||||
Millions of yen | Millions of yen | % | Yen | |||||||||||||||||||
As of December 31, 2022 | 56,122 | 30,392 | 49.8 | 1,771.74 | ||||||||||||||||||
As of December 31, 2021 | 54,533 | 27,323 | 45.9 | 1,589.37 | ||||||||||||||||||
(3) Consolidated cash flows | ||||||||||||||||||||||
Cash flows from | Cash flows from | Cash flows from | Cash and cash equivalents | |||||||||||||||||||
operating activities | investing activities | financing activities | at end of period | |||||||||||||||||||
Millions of yen | Millions of yen | Millions of yen | Millions of yen | |||||||||||||||||||
Year ended December 31, 2022 | 2,317 | (885) | (1,962) | 6,263 | ||||||||||||||||||
Year ended December 31, 2021 | 4,722 | (994) | (5,024) | 6,373 | ||||||||||||||||||
2. Cash dividends | ||||||||||||||||||||||
Annual dividends per share | Total cash | Dividend payout | Ratio of dividends | |||||||||||||||||||
to net assets | ||||||||||||||||||||||
1st quarter-end | 2nd quarter-end | 3rd quarter-end | Fiscal year-end | Total | dividends (Total) | ratio (Consolidated) | (Consolidated) | |||||||||||||||
Yen | Yen | Yen | Yen | Yen | Millions of yen | % | % | |||||||||||||||
Year ended December 31, 2021 | - | 8.00 | - | 14.00 | 22.00 | 351 | 13.3 | 1.4 | ||||||||||||||
Year ended December 31, 2022 | - | 11.00 | - | 19.00 | 30.00 | 483 | 22.4 | 1.7 | ||||||||||||||
Year ending December 31, 2023 | - | 16.00 | - | 16.00 | 32.00 | 29.7 | ||||||||||||||||
(Forecast) | ||||||||||||||||||||||
1
3. Forecast of consolidated financial results for the year ending December 31, 2023 (from January 1, 2023 to December 31, 2023)
Percentages indicate year-on-year changes
Net sales | Operating profit | Ordinary profit | Profit attributable to | Earnings per share | |||||||
owners of parent | |||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen | |||
Full year | 52,000 | 2.7 | 2,700 | 2.7 | 2,800 | (10.6) | 1,700 | (19.6) | 107.78 | ||
4. Notes | |||||||||||
(1) Changes in significant subsidiaries during the year ended December 31, 2022 | No | ||||||||||
(changes in specified subsidiaries resulting in the change in scope of consolidation): | |||||||||||
(2) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements | |||||||||||
Changes in accounting policies due to revisions to accounting standards and other regulations: | Yes | ||||||||||
Changes in accounting policies due to other reasons: | No | ||||||||||
Changes in accounting estimates: | No | ||||||||||
Restatement of prior period financial statements: | No |
(3) Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares)
As of December 31, 2022 | 17,710,000 | shares | As of December 31, 2021 | 17,710,000 | shares | |
Number of treasury shares at the end of the period | ||||||
As of December 31, 2022 | 1,928,421 | shares | As of December 31, 2021 | 1,948,421 | shares | |
Average number of shares during the period | ||||||
Year ended December 31, 2022 | 15,772,810 | shares | Year ended December 31, 2021 | 15,749,890 | shares |
2
Consolidated financial statements
Consolidated balance sheets
(Millions of yen) | |||
As of December 31, 2021 | As of December 31, 2022 | ||
Assets | |||
Current assets | |||
Cash and deposits | 7,659 | 7,052 | |
Notes and accounts receivable - trade | 9,618 | - | |
Notes and accounts receivable - trade, and contract | - | 10,435 | |
assets | |||
Merchandise and finished goods | 4,895 | 6,093 | |
Work in process | 669 | 949 | |
Raw materials and supplies | 3,766 | 4,363 | |
Other | 952 | 962 | |
Allowance for doubtful accounts | (0) | (1) | |
Total current assets | 27,562 | 29,855 | |
Non-current assets | |||
Property, plant and equipment | |||
Buildings and structures | 26,509 | 27,396 | |
Accumulated depreciation | (13,225) | (14,249) | |
Buildings and structures, net | 13,283 | 13,147 | |
Machinery, equipment and vehicles | 19,901 | 20,835 | |
Accumulated depreciation | (16,314) | (17,831) | |
Machinery, equipment and vehicles, net | 3,587 | 3,004 | |
Tools, furniture and fixtures | 3,914 | 4,157 | |
Accumulated depreciation | (3,314) | (3,459) | |
Tools, furniture and fixtures, net | 599 | 697 | |
Land | 5,247 | 5,352 | |
Leased assets | 339 | 333 | |
Accumulated depreciation | (172) | (213) | |
Leased assets, net | 167 | 119 | |
Construction in progress | 392 | 90 | |
Total property, plant and equipment | 23,277 | 22,411 | |
Intangible assets | |||
Other | 298 | 399 | |
Total intangible assets | 298 | 399 | |
Investments and other assets | |||
Investment securities | 1,706 | 1,716 | |
Investments in capital | 2 | 2 | |
Guarantee deposits | 356 | 285 | |
Deferred tax assets | 980 | 1,022 | |
Other | 348 | 433 | |
Allowance for doubtful accounts | (0) | (5) | |
Total investments and other assets | 3,394 | 3,455 | |
Total non-current assets | 26,970 | 26,266 | |
Total assets | 54,533 | 56,122 |
3
(Millions of yen) | |||
As of December 31, 2021 | As of December 31, 2022 | ||
Liabilities | |||
Current liabilities | |||
Notes and accounts payable - trade | 6,619 | 6,544 | |
Short-term borrowings | 5,662 | 5,168 | |
Lease liabilities | 48 | 44 | |
Accounts payable - other | 1,539 | 1,367 | |
Income taxes payable | 570 | 481 | |
Accrued consumption taxes | 142 | 158 | |
Provision for bonuses | 772 | 788 | |
Provision for bonuses for directors (and other | 35 | 17 | |
officers) | |||
Other | 1,312 | 1,416 | |
Total current liabilities | 16,702 | 15,987 | |
Non-current liabilities | |||
Long-term borrowings | 6,038 | 5,170 | |
Lease liabilities | 96 | 52 | |
Long-term accounts payable - other | 39 | 39 | |
Retirement benefit liability | 3,298 | 3,368 | |
Provision for share-based compensation | 115 | 160 | |
Long-term deposits received | 875 | 902 | |
Other | 42 | 49 | |
Total non-current liabilities | 10,506 | 9,742 | |
Total liabilities | 27,209 | 25,729 | |
Net assets | |||
Shareholders' equity | |||
Share capital | 2,898 | 2,898 | |
Capital surplus | 2,928 | 2,951 | |
Retained earnings | 19,284 | 21,006 | |
Treasury shares | (1,444) | (1,449) | |
Total shareholders' equity | 23,667 | 25,407 | |
Accumulated other comprehensive income | |||
Valuation difference on available-for-sale securities | 632 | 558 | |
Foreign currency translation adjustment | 1,002 | 2,194 | |
Remeasurements of defined benefit plans | (251) | (199) | |
Total accumulated other comprehensive income | 1,383 | 2,553 | |
Non-controlling interests | 2,272 | 2,432 | |
Total net assets | 27,323 | 30,392 | |
Total liabilities and net assets | 54,533 | 56,122 |
4
Consolidated statements of income and consolidated statements of comprehensive income Consolidated statements of income
(Millions of yen) | ||
Fiscal year ended | Fiscal year ended | |
December 31, 2021 | December 31, 2022 | |
Net sales | 48,474 | 50,627 |
Cost of sales | 32,431 | 34,456 |
Gross profit | 16,043 | 16,171 |
Selling, general and administrative expenses | 13,589 | 13,543 |
Operating profit | 2,453 | 2,628 |
Non-operating income | ||
Interest income | 43 | 40 |
Dividend income | 29 | 31 |
Share of profit of entities accounted for using equity method | 27 | 41 |
Foreign exchange gains | 109 | 208 |
Gain on forgiveness of debts | 64 | - |
Miscellaneous income | 211 | 292 |
Total non-operating income | 485 | 614 |
Non-operating expenses | ||
Interest expenses | 43 | 35 |
Sales discounts | 79 | - |
Swap Loss | 7 | 41 |
Loss on cancellation of leases | 20 | 14 |
Miscellaneous losses | 80 | 19 |
Total non-operating expenses | 232 | 110 |
Ordinary profit | 2,706 | 3,132 |
Extraordinary income | ||
Gain on sale of non-current assets | 607 | 23 |
Gain on sale of investment securities | 116 | - |
Subsidy income | - | 124 |
Compensation income | 92 | - |
Total extraordinary income | 816 | 147 |
Extraordinary losses | ||
Loss on retirement of non-current assets | 10 | 2 |
Loss on sale of non-current assets | 0 | 0 |
Loss on sale of investment securities | 33 | 7 |
Loss on valuation of investment securities | 18 | - |
Total extraordinary losses | 61 | 11 |
Profit before income taxes | 3,461 | 3,269 |
Income taxes - current | 906 | 1,031 |
Income taxes - deferred | (168) | (24) |
Total income taxes | 738 | 1,007 |
Profit | 2,723 | 2,262 |
Profit attributable to non-controlling interests | 127 | 147 |
Profit attributable to owners of parent | 2,595 | 2,114 |
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
NICCA Chemical Co. Ltd. published this content on 10 February 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 February 2023 02:45:05 UTC.